HERCULES, Calif., September 10, 2008 – Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, today announced the outcome of a new phage display study that augments the previously demonstrated utility of the ProteOn™ XPR36 protein interaction array system. Based on Surface Plasmon Resonance (SPR), the Proteon XPR36 system is capable of rapid screening of monoclonal antibody (mAb) supernatants.
